Maitreya Medicare Limited (NSE:MAITREYA)
India · Delayed Price · Currency is INR 126.75
-9.60 (-7.04%)
Jul 13, 2026, 3:27 PM IST
Maitreya Medicare Income Statement
Financials in millions INR. Fiscal year is April - March.
Millions INR. Fiscal year is Apr - Mar.
Fiscal Year | FY 2026 | FY 2025 | FY 2024 | FY 2023 | FY 2022 |
|---|---|---|---|---|---|
Period Ending | Mar '26 Mar 31, 2026 | Mar '25 Mar 31, 2025 | Mar '24 Mar 31, 2024 | Mar '23 Mar 31, 2023 | Mar '22 Mar 31, 2022 |
| 448.5 | 466.62 | 477.63 | 393.8 | 494.12 | |
Revenue Growth (YoY) | -3.88% | -2.31% | 21.29% | -20.30% | -12.72% |
Cost of Revenue | 151.29 | 150.75 | 148.97 | 131.94 | 163.15 |
Gross Profit | 297.21 | 315.87 | 328.66 | 261.86 | 330.97 |
Selling, General & Admin | - | 24.1 | 23.62 | 22.27 | 20.63 |
Other Operating Expenses | 300.55 | 240.4 | 244.12 | 162.81 | 274.74 |
Operating Expenses | 315.77 | 278.93 | 280.46 | 198 | 308.61 |
Operating Income | -18.56 | 36.94 | 48.2 | 63.87 | 22.35 |
Interest Expense | -14.84 | -6.79 | -6.88 | -5.35 | -6.06 |
Interest & Investment Income | - | 2.96 | 1.52 | 0.85 | 0.31 |
Other Non Operating Income (Expenses) | 8.69 | -1.23 | -1.55 | 0.15 | -1.72 |
EBT Excluding Unusual Items | -24.71 | 31.88 | 41.3 | 59.51 | 14.89 |
Gain (Loss) on Sale of Investments | - | 0.23 | 0.26 | 0.07 | 0.91 |
Gain (Loss) on Sale of Assets | - | - | - | - | 0.01 |
Other Unusual Items | - | - | 0.29 | -0.32 | - |
Pretax Income | -24.71 | 32.1 | 41.85 | 59.26 | 15.96 |
Income Tax Expense | -0.06 | 13.38 | 12.15 | 16.74 | 4.6 |
Net Income | -24.65 | 18.72 | 29.7 | 42.53 | 11.36 |
Preferred Dividends & Other Adjustments | - | - | 3.56 | 8.88 | - |
Net Income to Common | -24.65 | 18.72 | 26.13 | 33.64 | 11.36 |
Net Income Growth | - | -36.95% | -30.17% | 274.24% | -73.22% |
Shares Outstanding (Basic) | 7 | 7 | 7 | 5 | 5 |
Shares Outstanding (Diluted) | 7 | 7 | 7 | 5 | 5 |
Shares Change (YoY) | -0.05% | - | 36.61% | - | - |
EPS (Basic) | -3.64 | 2.76 | 3.86 | 6.78 | 2.29 |
EPS (Diluted) | -3.64 | 2.76 | 3.86 | 6.78 | 1.71 |
EPS Growth | - | -28.35% | -43.11% | 296.49% | -78.78% |
Free Cash Flow | -188 | 26.76 | -41.17 | 25.55 | -8.17 |
Free Cash Flow Per Share | -27.76 | 3.95 | -6.08 | 5.15 | -1.65 |
Gross Margin | 66.27% | 67.69% | 68.81% | 66.50% | 66.98% |
Operating Margin | -4.14% | 7.92% | 10.09% | 16.22% | 4.52% |
Profit Margin | -5.50% | 4.01% | 5.47% | 8.54% | 2.30% |
Free Cash Flow Margin | -41.92% | 5.73% | -8.62% | 6.49% | -1.65% |
EBITDA | -3.34 | 51.36 | 60.92 | 76.78 | 35.57 |
EBITDA Margin | -0.74% | 11.01% | 12.75% | 19.50% | 7.20% |
D&A For EBITDA | 15.22 | 14.42 | 12.72 | 12.91 | 13.21 |
EBIT | -18.56 | 36.94 | 48.2 | 63.87 | 22.35 |
EBIT Margin | -4.14% | 7.92% | 10.09% | 16.22% | 4.52% |
Effective Tax Rate | - | 41.67% | 29.04% | 28.24% | 28.80% |
Revenue as Reported | 458.37 | 472.34 | 480.35 | 399.49 | 497.44 |
Advertising Expenses | - | 0.3 | 0.31 | 0.35 | - |